Unaudited Standalone Financial Results For Quarter And Nine Months Ended December 31, 2017
Unaudited Standalone Financial Results for quarter and nine months ended December 31, 201710-01-2018
10-01-2018
Meeting Updates
Authorization of KMP for determining materiality of information and to make disclosure to Stock Exchanges.10-01-2018
Shareholding for the Period Ended December 13, 2017
Shalby Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 13, 2017. For more details, kindly Click here06-01-2018
A) Corporate Announcement Under Regulation 29(1)Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 ('The SEBI LODR') Regarding Intimation Of The Board Meeting Of The Company To Consider And Approve Unaudited Standalone Financial Results For Third Quarter Ended On December 31, 2017 B) Intimation Of Trading Window Closure In Terms Of 'Code Of Conduct To Regulate, Monitor And Report Trading By Insiders'
Notice is hereby given, pursuant to Regulation 29 read with Regulation 33 of SEBI LODR, that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, January 9, 2018, at the Registered office of the Company to consider, approve and take on record inter alia, the Unaudited Standalone Financial Results of the Company for the 3rd quarter / nine months ended on December 31, 2017....28-12-2017
Vikram Shah on Shalby Hospitals'high margins
There are enough hospitals where prices are driven by competition rather than capping.15-12-2017
Shalby Hospitals debuts lower than IPO price
Shalby Hospitals made its stock market debut at a discount of 4.4%, at Rs 237 per share on the BSE compared to its issue price of Rs 248 apiece. The share price has recovered somewhat since the debut. The Ahmedabad-based hospital had seen lukewarm demand for its Rs 504 crore initial public offering, which was subscribed 1.08 times by the final day. The company sold shares at Rs 245-248 apiece via the IPO, valuing it around Rs 2,680 crore. Shalby is the market leader for joint replacement surgery procedures, with a 15% market share of all such surgeries conducted by private corporate hospitals in India. However a recent ruling setting a price ceiling for knee implants is likely to impact revenues for the firm in the coming quarters. Shalby said that it plans to use the proceeds from the share sale for bringing down debt, purchase of medical equipment for the existing and recently set-up as well as upcoming hospitals.15-12-2017
Listing of equity shares of Shalby Ltd
Trading Members of the Exchange are hereby informed that effective from December 15, 2017, the equity shares of Shalby Ltd (Scrip Code: 540797) are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. For further details please refer to the notice no 20171214- dated December 14, 2017.15-12-2017
Shalby Hospitals to debut on Friday
Multi-specialty hospital chain Shalby Ltd, which recently concluded its Rs 504-crore initial public offering, will list its shares on the exchanges tomorrow. The equity shares will be listed on the...14-12-2017
Shalby Limited (IPO): Good health at a cost
This leader in orthopaedic care can benefit from expansion. But the asking price is high03-12-2017